Selecta Biosciences, Inc.

Selecta Biosciences, Inc.verified

SELB

Price:

$0.8812

Market Cap:

$135.20M

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies c...[Read more]

Industry

Biotechnology

IPO Date

2016-06-22

Stock Exchange

NASDAQ

Ticker

SELB

The PE Ratio as of June 2024 (TTM) for Selecta Biosciences, Inc. (SELB) is -3.04

According to Selecta Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.04. This represents a change of 16.88% compared to the average of -2.60 of the last 4 quarters.

Selecta Biosciences, Inc. (SELB) Historical PE Ratio (quarterly & annually)

How has SELB PE Ratio performed in the past?

The mean historical PE Ratio of Selecta Biosciences, Inc. over the last ten years is -51.75. The current -3.04 PE Ratio has changed 487.22% with respect to the historical average. Over the past ten years (40 quarters), SELB's PE Ratio was at its highest in in the June 2021 quarter at 25.99. The PE Ratio was at its lowest in in the September 2016 quarter at -8.35.

Quarterly (TTM)
Annual

Average

-51.75

Median

-4.68

Minimum

-471.10

Maximum

4.66

Selecta Biosciences, Inc. (SELB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Selecta Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 230.22%

Maximum Annual PE Ratio = 4.66

Minimum Annual Increase = -10211.05%

Minimum Annual PE Ratio = -471.10

Quarterly (TTM)
Annual
YearPE RatioChange
2023-471.10-10211.05%
20224.66-132.11%
2021-14.51230.22%
2020-4.39117.00%
2019-2.02122.14%
2018-0.91-70.28%
2017-3.07-38.28%
2016-4.97-30.55%
2015-7.16-48.84%

Selecta Biosciences, Inc. (SELB) Average PE Ratio

How has SELB PE Ratio performed in the past?

The current PE Ratio of Selecta Biosciences, Inc. (SELB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-160.32

5-year avg

-97.47

10-year avg

-51.75

Selecta Biosciences, Inc. (SELB) PE Ratio vs. Peers

How is SELB’s PE Ratio compared to its peers?

Selecta Biosciences, Inc.’s PE Ratio is greater than Paratek Pharmaceuticals, Inc. (-3.05), greater than Corvus Pharmaceuticals, Inc. (-3.81), greater than Immutep Limited (-79.65), greater than Icosavax, Inc. (-8.27), less than Checkpoint Therapeutics, Inc. (-1.28), less than Mustang Bio, Inc. (-0.21), less than Reviva Pharmaceuticals Holdings, Inc. (-0.93), less than Fortress Biotech, Inc. (-0.57), less than Kodiak Sciences Inc. (-0.61), less than Reviva Pharmaceuticals Holdings, Inc. (-0.93), less than Eyenovia, Inc. (-0.92), less than Cognition Therapeutics, Inc. (-2.57), less than TransCode Therapeutics, Inc. (-0.34), less than Gamida Cell Ltd. (-0.23), greater than Rigel Pharmaceuticals, Inc. (-8.20), greater than Geron Corporation (-13.99), greater than ImmunoGen, Inc. (-122.93), less than Cidara Therapeutics, Inc. (-1.57), less than Fortress Biotech, Inc. (-0.57),

Build a custom stock screener for Selecta Biosciences, Inc. (SELB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Selecta Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Selecta Biosciences, Inc. (SELB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Selecta Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Selecta Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Selecta Biosciences, Inc. (SELB)?

What is the highest PE Ratio for Selecta Biosciences, Inc. (SELB)?

What is the 3-year average PE Ratio for Selecta Biosciences, Inc. (SELB)?

What is the 5-year average PE Ratio for Selecta Biosciences, Inc. (SELB)?

How does the current PE Ratio for Selecta Biosciences, Inc. (SELB) compare to its historical average?